Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the notices for Revision: v3.4.1 and the government funding lapse notice.
    Difference
    0.3%
    Check dated 2026-02-11T01:50:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Site-wide notice added about a lapse in government funding and NIH Clinical Center operations; Revision: v3.4.1 replaces v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-03T23:18:01.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    UI updates include displaying the glossary toggle and adding a 'Last Update Submitted that Met QC Criteria' label, and a 'No FEAR Act Data' note was added with the revision bumped to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T15:52:54.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision from v3.3.3 to v3.3.4 represents a minor update to the page, with no changes to study details or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T11:52:54.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry have been removed. These changes do not affect the study information or page functionality.
    Difference
    0.1%
    Check dated 2025-12-21T21:09:38.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T05:40:36.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.